ro.co glp-1 Hannah's on Ro Ro (@ro) / Posts /

Objective To determine whether the use of glucagon-like peptide-1 (GLP-1) receptor agonists is associated with an increased risk of suicidal ideation, self-harm, and suicide among patients with type 2 diabetes compared with the use of dipeptidyl peptidase-4 (DPP-4) inhibitors or sodium-glucose cotransporter-2 (SGLT-2) inhibitors

In real-world settings multiple factors contribute to non-persistence, including adverse effects, high cost-sharing and weight loss not meeting patients' expectations.

Personalized treatment plans based on your unique metabolic profile

I went from a 'moon face' to a noticeably slimmer look with a defined jawline

Millions take GLP-1 medications, but few know their oral side effects

Understand each dose for Tirzepatide and Semaglutide